Our model's win probability vs. the market's implied probability. The gap is the edge.
Every factor that moved the model. Every number sourced — no hallucinations.
Supreme Brain assigns Philadelphia -1.5 a 50.0% win probability against a 50.0% market-implied probability at +140 odds, creating a +5.0% expected-value edge on the current price. The model recommends a quarter-Kelly stake of 0.14 units. Detroit enters with 15 players on the injury report compared to Philadelphia's six, a depth disparity that tilts multi-run outcomes toward the visitor. The primary risk is the single-run win—road chalk that covers the moneyline but dies on the runline. Plus-money runlines on road favorites typically signal market skepticism about blowout probability, but the injury gap and model edge justify the contrarian position. This is a high-conviction play on Philadelphia's ability to win by two or more, not merely to win.
Supreme Brain assigns Philadelphia -1.5 a 50.0% win probability at +140 odds, a five-point edge over the market-implied probability. Detroit enters the matchup with 15 players on the injury report—more than double Philadelphia's six.
The thesis: Philadelphia's depth advantage and a mispriced runline create a +5.0% expected-value opportunity, with the model recommending a quarter-Kelly stake of 0.14 units on the road favorite to win by multiple runs.
A single-run Philadelphia win breaks the thesis. If Detroit's depleted roster keeps the game tight—manufacturing just enough offense to stay within a run through seven or eight innings—the runline dies even as the moneyline cashes. Supreme Brain flags this scenario explicitly: single-run wins are the runline killer, and road chalk grinding out narrow victories is the most common way this bet loses while the favorite still wins.
Philadelphia needs to win by two. The injury report and the model edge suggest they can. The plus-money price suggests the market isn't sure—and that's where the value lives.